Suggestions for the next USPTO director, AIPLA’s advice for US president-elect Trump, an injunction preventing Sanofi selling a drug during the term of two Amgen patents, a review of software copyright litigation since Oracle v Google, a list of top global innovators, and reviews of 2016 for patent licensing stocks and the PTAB were in the recent intellectual property headlines
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
In the eighth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Ability, a network for disabled people and carers active in the IP profession
The longest government shutdown in US history froze ITC operations, yet IP practices stayed steady as firms relied on early preparation and client communication
The 2026 Life Sciences EMEA Awards is now open for entries. We are looking forward to reviewing and celebrating the industry's most impressive achievements and landmarks from the past year.
The tie-up between Perkins Coie and Ashurst may generate some striking numbers, but independent IP firms need not worry yet, according to practitioners
Perkins Coie’s US patent prosecution strength could provide Ashurst with an opportunity to enter an untapped market in Australia, but it may not be easy
Mitesh Patel at Reed Smith outlines why the US Copyright Office and courts have so far dismissed AI authorship and how inventors can protect AI-generated works